These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19183316)

  • 1. Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London.
    Khan H; Lasker SS; Chowdhury TA
    Diabet Med; 2008 Sep; 25(9):1108-11. PubMed ID: 19183316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.
    Hajos TR; Pouwer F; de Grooth R; Holleman F; Twisk JW; Diamant M; Snoek FJ
    Diabet Med; 2011 Sep; 28(9):1096-102. PubMed ID: 21843305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The perceived barriers to insulin therapy among type 2 diabetic patients.
    Hussein A; Mostafa A; Areej A; Mona AM; Shimaa A; Najd AG; Futoon A
    Afr Health Sci; 2019 Mar; 19(1):1638-1646. PubMed ID: 31148993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town.
    Haque M; Emerson SH; Dennison CR; Navsa M; Levitt NS
    S Afr Med J; 2005 Oct; 95(10):798-802. PubMed ID: 16341336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring reasons for very poor glycaemic control in patients with Type 2 diabetes.
    Khan H; Lasker SS; Chowdhury TA
    Prim Care Diabetes; 2011 Dec; 5(4):251-5. PubMed ID: 21782539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
    Batais MA; Schantter P
    Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care.
    Hajos TR; Pouwer F; de Grooth R; Holleman F; Twisk JW; Diamant M; Snoek FJ
    Qual Life Res; 2012 Oct; 21(8):1359-65. PubMed ID: 22065281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with psychological insulin resistance in individuals with type 2 diabetes.
    Nam S; Chesla C; Stotts NA; Kroon L; Janson SL
    Diabetes Care; 2010 Aug; 33(8):1747-9. PubMed ID: 20435797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE.
    Dornhorst A; Lüddeke HJ; Koenen C; Meriläinen M; King A; Robinson A; Sreenan S;
    Diabetes Obes Metab; 2008 Jan; 10(1):75-81. PubMed ID: 18034846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
    Polonsky WH; Fisher L; Guzman S; Villa-Caballero L; Edelman SV
    Diabetes Care; 2005 Oct; 28(10):2543-5. PubMed ID: 16186296
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study.
    Calvert MJ; McManus RJ; Freemantle N
    Br J Gen Pract; 2007 Jun; 57(539):455-60. PubMed ID: 17550670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore.
    Wong S; Lee J; Ko Y; Chong MF; Lam CK; Tang WE
    Diabet Med; 2011 Feb; 28(2):206-11. PubMed ID: 21219431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
    Ji L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
    Adv Ther; 2019 Jun; 36(6):1485-1496. PubMed ID: 31004325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.